New Search

Export article
Open Access
Preprint - version 1 (latest)

Heterogeneous network-based drug repurposing for COVID-19

Shuting Jin, Xiangxiang Zeng, Wei Huang, Feng Xia, Changzhi Jiang, Xiangrong Liu, Shaoliang Peng
Published: 20 July 2021
Abstract: The Corona Virus Disease 2019 (COVID-19) belongs to human coronaviruses (HCoVs), which spreads rapidly around the world. Compared with new drug development, drug repurposing may be the best shortcut for treating COVID-19. Therefore, we constructed a comprehensive heterogeneous network based on the HCoVs-related target proteins and use the previously proposed deepDTnet, to discover potential drug candidates for COVID-19. We obtain high performance in predicting the possible drugs effective for COVID-19 related proteins. In summary, this work utilizes a powerful heterogeneous network-based deep learning method, which may be beneficial to quickly identify candidate repurposable drugs toward future clinical trials for COVID-19. The code and data are available at https://github.com/stjin-XMU/HnDR-COVID.

Share this article

Back to Top Top